Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Total Liabilities: 2023-2024

Historic Total Liabilities for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $57.5 million.

  • Zenas BioPharma's Total Liabilities rose 185.45% to $125.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $125.6 million, marking a year-over-year increase of 185.45%. This contributed to the annual value of $57.5 million for FY2024, which is 31.26% up from last year.
  • Zenas BioPharma's Total Liabilities amounted to $57.5 million in FY2024, which was up 31.26% from $43.8 million recorded in FY2023.
  • In the past 5 years, Zenas BioPharma's Total Liabilities registered a high of $57.5 million during FY2024, and its lowest value of $43.8 million during FY2023.
  • For the 2-year period, Zenas BioPharma's Total Liabilities averaged around $50.7 million, with its median value being $50.7 million (2023).
  • Data for Zenas BioPharma's Total Liabilities shows a peak YoY spiked of 31.26% (in 2024) over the last 5 years.
  • Over the past 2 years, Zenas BioPharma's Total Liabilities (Yearly) stood at $43.8 million in 2023, then surged by 31.26% to $57.5 million in 2024.